Literature DB >> 26275808

The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients.

Agnieszka Nielepkowicz-Goździńska1, Wojciech Fendler2, Ewa Robak3, Lilianna Kulczycka-Siennicka3, Paweł Górski4, Tadeusz Pietras4, Ewa Brzeziańska5, Małgorzata Pietrusińska4, Adam Antczak6.   

Abstract

The inflammatory process in systemic lupus erythematosus (SLE) affects many organs including the lungs. CXC chemokines are suggested to play an important role in the pathogenesis of SLE and pulmonary fibrosis. To estimate the concentrations of CXCL9, CXCL10, CXCL11 in bronchoalveolar lavage fluid (BALF) of patients with and without pulmonary involvements of SLE to evaluate CXC chemokines role in the pathogenesis of pulmonary fibrosis in SLE. Twenty-six SLE patients and 31 healthy controls were evaluated using high-resolution computed tomography (HRCT), pulmonary function tests, the SLE Disease Activity Index (SLEDAI), assessing CXCL9, CXCL11, CXCL10 level in BALF (an enzyme-immunosorbent assay kit). The mean CXCL9 and CXCL11 concentrations in BALF were higher in SLE patients compared to healthy controls (34.09 ± 102.34 vs 10.98 ± 14.65 pg/mL, p < 0.001; 72.65 ± 112.89 vs 16.12 ± 83.75 pg/mL, p = 0.012, respectively). The disease activity scored by SLEDAI and the concentration of CXCL10 in BALF were significantly higher in the SLE patients with pulmonary fibrosis when compared with patients with normal HRCT (8.23 ± 3.19 vs 5.01 ± 2.41; 73.45 ± 34.12 vs 40.76 ± 41.65, respectively, in both p < 0.05). In SLE patients positive correlations were found between SLEDAI and the percentage of lymphocytes in BALF (r = 0.51, p < 0.05); CXCL9 and CXCL10 concentrations in BALF (r = 0.65, p < 0.001); CXCL9 and CXCL11 concentrations in BALF (r = 0.69, p < 0.001). In lupus patients with pulmonary manifestations positive correlations were found between CXCL11 concentration in BALF and SLEDAI (r = 0.55, p < 0.05), CXCL11 concentration and the percentage of neutrophils in BALF (r = 0.69, p < 0.05), CXCL10 concentration and the percentage of neutrophils in BALF (r = 0.57, p < 0.05). Our observations indicate that CXCL9 and CXCL11 play an important role in the pathogenesis of SLE but it needs further studies. These results suggest that CXCL10 and CXCL11 are associated with neutrophils accumulation in the alveolar space of SLE patients with pulmonary fibrosis and should be considered as potential factor of interstitial fibrosis.

Entities:  

Keywords:  Bronchoalveolar lavage fluid; CXCL10; CXCL11; CXCL9; Pulmonary fibrosis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 26275808     DOI: 10.1007/s00005-015-0356-8

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  4 in total

1.  Relationship between rs1801157 polymorphism in stromal cell-derived factor gene and systemic lupus erythematosus risk.

Authors:  Can Qian; Qinghua Zou; Yong Wang
Journal:  Oncotarget       Date:  2017-08-01

Review 2.  Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Huixia Wang; Jiaxing Wang; Yumin Xia
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

3.  CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.

Authors:  Masami Kameda; Mitsuo Otsuka; Hirofumi Chiba; Koji Kuronuma; Takehiro Hasegawa; Hiroki Takahashi; Hiroki Takahashi
Journal:  PLoS One       Date:  2020-11-02       Impact factor: 3.240

4.  Expression and potential role of CXCL5 in the pathogenesis of intrauterine adhesions.

Authors:  Zi-Ang Fang; Yu He; Chao Sun; Lei Zhan; Guiju Zhou; Bing Wei; Shiying Sun
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.